Epsilon M&A Deal Report - Farma-APS Produtos Farmaceuticos
Transaction Multiples for the Valuation of Private Companies

Private Group led by Magnum Industrial Partners > Farma-APS Produtos Farmaceuticos
Announced Date : 02 December 2008
Type : MBO (Management Buy Out)
Deal Value : Yes
Acquirer : Private Group led by Magnum Industrial Partners
Target Farma-APS Produtos Farmaceuticos
Target Country Portugal
Sector of activity : Health, Pharmaceuticals & Biotechnology
> Founded in 1982, Farma APS Produtos Farmaceuticos SA is a drug development, contract manufacturing and licensing-out company specialized in the manufacturing of solid oral do ...

Transaction multiples available
EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
---|---|---|---|---|---|---|---|
Historic | |||||||
Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating *
Source: Epsilon Research / EMAT

Comparable Transactions
Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226
Example of comparable transactions on EMAT (same sub-sector):
Date | Acquirer | Target | Country | Multiples | See details |
---|---|---|---|---|---|
16/07/2007 | Private Group led by UI Gestion | Euroline-Didactic | France | 0 | |
28/09/2008 | Private Group led by Naxicap Partners | Laboratoire Nuxe | France | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database